Products

What will AGI do for Betamethasone benzoate?

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 877K0XW47A, chemically known as pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.beta.)- but more generally known as betamethasone benzoate, which bears US NIH Compound Identifier 571358. The base compound, Betamethasone, comes in many other forms, including base, acetate, acetate phosphate, acibutate, alcohol, butyrate propionate, dihydrogen phosphate, dipropionate, disodium phosphate, phosphate, sodium, sodium phosphate, valerate, 17, 21-dipropionate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, 21-phosphate disodium, and 21-valerate. European Medicines Agency schedules Betamethasone benzoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00781MIG. Most nations, for tariff and trade purposes, schedule betamethasone benzoate under HS 29372200 and SITC 54153. As of Q4 2014, BETAMETHASONE BENZOATE remains US FDA's Preferred Term for this commodity. Betamethasone benzoate bears US NLM identifiers UMLS ID C0005311 and NCI Concept Code C65257. SMILES: C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)OC(=O)C5CCCCC5)C)O)F)C.